A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy

NCT03764072 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Pain

Interventions

DRUG: VX-150
DRUG: Placebo

Sponsor

Vertex Pharmaceuticals Incorporated